Vesuvius Pharmaceuticals
Boston, US · Founded 2014 · Delaware corporation · 1 known investors
Founders & leadership
DH
DC
David CordoExecutive
Board
LE
AO
Arnold OronskyBoard director
PG
Phil GutryBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.2M disclosed across 1 round · 2014
▶$10.2MraisedJan 2015 · 5 investors · PharmaceuticalsRule 506(b)
▶$10.2MraisedJan 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- Daniel HicklinExecutive Officer, Director
- Arnold OronskyDirector
- David CordoExecutive Officer
- Phil GutryDirector
- Offering amount
- $33M
- Amount sold
- $10.2M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Vesuvius Pharmaceuticals went on to found or lead other companies.
Frequently asked questions
- Who are Vesuvius Pharmaceuticals's investors?
- Vesuvius Pharmaceuticals's investors include MPM BioImpact.
- How much funding has Vesuvius Pharmaceuticals raised?
- Vesuvius Pharmaceuticals has disclosed $10.2M raised across 1 round.
- Where is Vesuvius Pharmaceuticals headquartered?
- Vesuvius Pharmaceuticals is headquartered in Boston, US.